Malaria: all 1,315 studies
Page 7 of 14. Open to participants first (86), then studies with results posted, then the rest; newest registration first within each.
- Efficacy and Safety of Artemisinin-based Combination Treatments in the Democratic Republic of the CongoCompletedNCT02940756Phase 4
- Field Efficacy Of Insecticide Treated Uniforms And Skin Repellents for Malaria PreventionStatus unknownNCT02938975Phase 3
- Field Evaluation of a Device for Automated Malaria Microscopy (Autoscope Version 2)CompletedNCT02932072
- Mass Drug Administrations of DHA-PQP to Accelerate Towards Malaria Elimination in Magude District, Southern MozambiqueCompletedNCT02914145Not applicable
- Cost-effectiveness Evaluation of Vector Control Strategies in MozambiqueCompletedNCT02910934Not applicable
- Cardiac Safety of Dihydroartemisinin-Piperaquine Amongst Pregnant Women in TanzaniaCompletedNCT02909712Phase 2
- A Safety and Efficacy Study of R21 +/- ChAd63/MVA ME-TRAPCompletedNCT02905019Phase 1/2
- Frequency and Distribution of Mixed Falciparum-vivax Infections in French GuianaCompletedNCT02903758
- Prevalence of Malaria Parasites in People Working in Illegal Gold Mining in French GuianaCompletedNCT02903706
- Use of Malaria Rapid Diagnostic Tests as a Decision Aid for the Management of Fever by International TravelersWithdrawnNCT02900079
- Metabolism and Pharmacokinetics of Primaquine Enantiomers in Human Volunteers, Study 1CompletedNCT02898779Phase 1
- Prevalence Survey of Plasmodium Falciparum Antimalarial Drug Resistance MarkersCompletedNCT02895568
- Evaluation of Seasonal Malaria Chemoprevention in KitaCompletedNCT02894294
- The Effect of Vitamin A With and Without Zinc and Multivitamin Supplementation on Malaria Morbidity in Ghanaian ChildrenCompletedNCT02878265Phase 3
- RHOST-cRCT, Reactive Household-based Self-administered Treatment Against Residual Malaria TransmissionCompletedNCT02878200Not applicable
- G6PD Assessment Before Primaquine for Radical Treatment of Vivax MalariaCompletedNCT02876549Phase 4
- Safety, Tolerability and Immunogenicity of PfSPZ Vaccine in an Age De-escalation Trial in Equatorial Guinea.CompletedNCT02859350Phase 1
- Safety and Protective Efficacy of IV Immunization With Cryopreserved PfSPZ Under A/P ChemoprophylaxisCompletedNCT02858817Phase 1
- Controlled Human Malaria Infection Model for Evaluation of Transmission-Blocking Interventions - Study 1CompletedNCT02836002Phase 1/2
- Phase 2 Efficacy Study of Primaquine and Methylene BlueCompletedNCT02831023Phase 2
- Cohort Event Monitoring in Sub Saharan AfricaCompletedNCT02817919
- Leiden University Medical Center Mini Donor BankWithdrawnNCT02810613
- P.Vivax Treatment TrialCompletedNCT02802813Phase 1/2
- Child Follow-up Until 2 YearsCompletedNCT02800109
- Diagnostic Utility of Volatile Organic Compounds in Human Breath for Acute Clinical Malaria in EthiopiaWithdrawnNCT02793414
- A Trial on Supervised Primaquine Use in EthiopiaWithdrawnNCT02793388Phase 4
- Early Life Cohort in Papua Indonesia (ELIPI Study)CompletedNCT02793336
- Molecular Surveillance of Artemisinin Resistance Malaria in MyanmarCompletedNCT02792816
- Prevention of Malaria With Dihydroartemisinine + Piperaquine for Forest RangersCompletedNCT02788864Phase 4
- A Randomized Controlled Trial on Malaria Primaquine Treatment in Timika, Indonesia (TRIPI)CompletedNCT02787070Phase 4
- MMV390048 and Its Antimalarial Activity Against Plasmodium Falciparum in Healthy Adult Subjects, Part BCompletedNCT02783833Phase 1/2
- PfSPZ Challenge in Non-immune Adults in Baltimore, USACompletedNCT02780154Phase 1
- PfSPZ Challenge in Healthy Malaria-Naïve Adults in the United StatesCompletedNCT02773979Phase 1
- Assessing the Effect of Neglected Tropical Diseases on Plasmodium Falciparum Transmission in an Area of Co-endemicityCompletedNCT02769013
- The Impact of Sulphadoxine-Pyrimethamine Use At Scale on Newborn Outcomes in NigeriaCompletedNCT02758353Not applicable
- A Study to Assess the Effects of Dissolution Profile on the Pharmacokinetics of Single Oral Doses of Tafenoquine Tablets and Tafenoquine Stable Isotope Labelled SolutionCompletedNCT02751294Phase 1
- Lumefantrine in Venous Plasma Versus Dried Capillary Blood SpotCompletedNCT02742285Phase 4
- Efficacy of Artesunate-amodiaquine and Artemether-lumefantrine for Uncomplicated Malaria in South Kivu, DR CongoCompletedNCT02741024Phase 4
- Controlled Human Malaria Infection in Semi-Immune Kenyan Adults. (CHMI-SIKA)Status unknownNCT02739763Phase 1
- A Microdose Study in Healthy Subjects to Describe Intravenous Pharmacokinetics of GSK3191607CompletedNCT02737007Phase 1
- Delivery of Malaria Chemoprevention in the Post-discharge Management of Children With Severe Anaemia in MalawiStatus unknownNCT02721420Phase 3
- Effectiveness of Mass Drug Administration for Reducing Seasonal Malaria Transmission in ZanzibarCompletedNCT02721186Not applicable
- Molecular Assessment of Drug Resistance Markers in Asymptomatic Malaria Cases and Malaria Antibody KineticCompletedNCT02708199
- Sequential Optimization of Dose and Schedule of PfSPZ VaccineCompletedNCT02704533Phase 1
- Vanderbilt-Zambia Innovations in Global Health TechnologiesCompletedNCT02700269
- Evaluating the Role of Chloroquine for Malaria EliminationCompletedNCT02698748Phase 2/3
- Methylene Blue Against Vivax Malaria in EthiopiaWithdrawnNCT02696928Phase 2
- Rosiglitazone Adjunctive Therapy for Severe Malaria in ChildrenCompletedNCT02694874Not applicable
- Safety and Protective Efficacy of BCG Vaccination Against Controlled Human Malaria InfectionCompletedNCT02692963Phase 2
- Efficacy of Chloroquine (CQ) Alone Compared to Concomitant CQ and Primaquine for Plasmodium Vivax InfectionCompletedNCT02691910Phase 2/3
- Safety, Tolerability and Efficacy of PfSPZ Vaccine in Healthy Children and Infants 5 Months - 9 Years Living in KenyaCompletedNCT02687373Phase 1/2
- Feasibility of the Vapor Nanobubble Technology for Malaria Diagnostics (MalariaSense)CompletedNCT02672228Not applicable
- Post-discharge Malaria Chemoprevention(PMC) StudyCompletedNCT02671175Phase 3
- Optimizing Sysmex Technology as an Innovative Tool to Differentiate Between Malaria (PALUdism) and BACterial Infections in a Malaria Endemic RegionCompletedNCT02669823
- Safety and Immunogenicity of Sanaria's Irradiated Sporozoite Vaccine (PfSPZ Vaccine) in Malaria-Experienced Adults in Burkina FasoCompletedNCT02663700Phase 1
- First-in-Human Study of an Oral Plasmodium Falciparum Plasma Membrane Protein InhibitorCompletedNCT02661373Phase 1
- Impact of Antimalarial Treatment on Measures of T Cell Suppression/Regulation in Healthy Adults From Doneguebougou, MaliCompletedNCT02659566
- Assessment of Any Potential Retinal Effects of Tafenoquine (TQ)CompletedNCT02658435Phase 1
- Trial to Evaluate the Safety and Immunogenicity of a Placental Malaria Vaccine Candidate (PRIMVAC ) in Healthy AdultsCompletedNCT02658253Phase 1
- Community-led Responses for Elimination: Controlled Trial of Reactive Case Detection Versus Reactive Drug AdministrationCompletedNCT02654912Phase 4
- Evaluation of the Safety of Primaquine in Combination With Dihydroartemisinin-piperaquine in G6PD Deficient Males in The GambiaTerminatedNCT02654730Phase 2/3
- Malaria Elimination Pilot Study in Military Forces in CambodiaStatus unknownNCT02653898Phase 4
- Safety and Immunogenicity of the Placental Malaria Vaccine Candidate PAMVAC Variously AdjuvantedCompletedNCT02647489Phase 1
- Optimization of Seasonal Malaria Chemoprevention (SMC) DeliveryStatus unknownNCT02646410Not applicable
- Artemether-lumefantrine Resistance Monitoring in Children With Uncomplicated Plasmodium Falciparum Malaria in MaliCompletedNCT02645604
- Text Message Reminders to Health Workers on Malaria, Pneumonia, and Diarrhea Case Management in MalawiCompletedNCT02645513Not applicable
- Artemisinin Resistance In Malaria Treated With IV ArtesunateWithdrawnNCT02640495
- In Vivo Efficacy of Artemether-Lumefantrine and Artesunate-Amodiaquine for Uncomplicated P. Falciparum MalariaCompletedNCT02637128Phase 4
- Safety, Immunogenicity, and Protective Efficacy of Radiation Attenuated Plasmodium Falciparum NF54 Sporozoites in Healthy African Adults in MaliCompletedNCT02627456Phase 1
- Effect of Imatinib on Suppression of Malaria Parasites in Patients With Uncomplicated Plasmodium Falciparum MalariaCompletedNCT02614404Phase 1
- Safety and Immunogenicity in Age De-Escalation of PfSPZ Vaccine in Tanzanian Adults, Children, and InfantsCompletedNCT02613520Phase 1
- Efficacy, Safety, and Tolerability of Dihydroartemisinin-piperaquine + Mefloquine Compared to Dihydroartemisinin-piperaquine or Artesunate-mefloquine in Patients With Uncomplicated Falciparum Malaria in CambodiaCompletedNCT02612545Phase 1
- Evaluating the Efficacy of Chloroquine for the Treatment of Plasmodium Vivax Infections in Central VietnamStatus unknownNCT02610686Phase 4
- Evaluation of Reactive Focal Mass Drug Administration (rfMDA) +/- Reactive Focal Vector Control (RAVC) in NamibiaCompletedNCT02610400Phase 3
- Cardiac Safety of Repeated Doses of Dihydroartemisinin-Piperaquine for the Use in Mass Treatment CampaignsCompletedNCT02605720Phase 3
- P. Falciparum Resistance to Artemisinin in VietnamStatus unknownNCT02604966Phase 4
- PfSPZ Vaccine: Dose Optimization With Heterologous Challenge in Healthy Malaria-Naïve AdultsCompletedNCT02601716Phase 2
- A Study to Assess the Safety and Immunogenicity of a Malaria Vaccine Candidate, R21, Administered With AS01BCompletedNCT02600975Phase 1
- A Study to Assess Current Standard Malaria Treatment Guidelines in the Republic of the SudanCompletedNCT02592408Phase 4
- In-vivo Efficacy and Safety of Artemether/Lumefantrine Vs Dihydroartemisinin-piperaquine for Treatment of Uncomplicated Malaria and Assessment of Parasite Genetic Factors Associated With Parasite Clearance or Treatment FailureCompletedNCT02590627Phase 4
- A Safety, Tolerability, Pharmacokinetic and Efficacy Study of Azithromycin Plus Piperaquine as Presumptive Treatment in Pregnant PNG WomenStatus unknownNCT02575755Phase 4
- A Trial of the Efficacy of Artesunate and Three Quinine Regimens in the Treatment of Severe Malaria in Children at the Ebolowa Regional Hospital - CameroonCompletedNCT02563704Phase 3
- DSM265 Prophylaxis of Plasmodium Falciparum MalariaCompletedNCT02562872Phase 1
- Hati Salama (Secure Voucher)CompletedNCT02561624Not applicable
- Prophylaxis Against Malaria to Enhance Child Development (PROTECT Study)CompletedNCT02557425
- Targeted Indoor Residual Spraying Against MalariaCompletedNCT02556242Phase 4
- Markers of T Cell Suppression: Antimalarial Treatment and Vaccine Responses in Healthy Malian AdultsCompletedNCT02544048
- Effectiveness of KAE609 in Reducing Asexual & Sexual Blood-stage P.Falciparum Infection & Infectivity to MosquitosTerminatedNCT02543086Phase 1
- Accelerating the Reduction of Malaria Transmission in Kanel, Ranérou and Linguère DistrictsCompletedNCT02536222Phase 4
- Determining a Tolerable Dose of Primaquine in G6PD-deficient Persons Without Malaria in MaliCompletedNCT02535767Phase 1/2
- The Effectiveness of Non-Pyrethroid Insecticide-Treated Durable Wall Liners as a Method for Malaria Control in Endemic Rural TanzaniaTerminatedNCT02533336Phase 3
- A Clinical Trial to Assess the Safety and Immunogenicity of New Malaria Vaccine Candidates ChAd63 Pfs25-IMX313 and MVA Pfs25-IMX313CompletedNCT02532049Phase 1
- Relapses in Plasmodium Ovale and Efficacy of Artemether-lumefantrine for Mixed Species and Non-falciparum MalariaCompletedNCT02528279Not applicable
- A Comparative Study of Azithromycin and S-P as Prophylaxis in Pregnant HIV+ PatientsCompletedNCT02527005Phase 1
- A Comparative Study of Mefloquine and S-P as Prophylaxis Against Malaria in Pregnant HIV + PatientsCompletedNCT02524444Phase 1
- Community Point Distribution of Insecticide Treated Bed NetsCompletedNCT02517879Not applicable
- Efficacy and Safety of High-dose Ivermectin for Reducing Malaria Transmission: A Dose Finding StudyCompletedNCT02511353Phase 2
- Sanaria PfSPZ Challenge With Pyrimethamine Chemoprophylaxis (PfSPZ-CVac Approach): Phase 1 Trial to Determine Safety and Protective Efficacy of Sanaria PfSPZ Challenge With Concurrent Pyrimethamine Treatment That Inhibits Development of Asexual B...CompletedNCT02511054Phase 1
- Markers of T Cell Suppression: Associations With Malaria Infection and Antimalarial Treatment in Malian ChildrenCompletedNCT02504918
- Novel mHealth Platform to Ensure Quality of Community-based Malaria DiagnosisCompletedNCT02504593Not applicable